3- year efficacy and safety for liraglitude 3.0mg in adults with obesity/overweight, prediabetes and baseline BMI <35 vs >/=35kg/m2 in the SCALE obesity and and pore diabetes, double-blind, placebo-controlled trial

Thumbnail Image
Date
2007-09
Authors
Fasanmade, O
Greenway, F
Le Roux, C.W
McGowan, B
Pi-Sunyer, X
Cancino, A.P
Journal Title
Journal ISSN
Volume Title
Publisher
Endocrine and Metabolism Society of Nigeria
Abstract
Description
Keywords
Liraglutide, obesity, efficacy
Citation
Fasanmade O, Greenway F, Le Roux CW, McGowan B, Pi-Sunyer X, Cancino AP, Van Gaal L. 3- year efficacy and safety for liraglitude 3.0mg in adults with obesity/overweight, prediabetes and baseline BMI <35 vs >/=35kg/m2 in the SCALE obesity and and pore diabetes, double-blind, placebo-controlled trial. 2017 book of abstracts Endocrinology and Metabolism Society of Nigeria.